Triazine‐Naphthalimide Cage for the Recognition of Nucleotides and Parallel G‐Quadruplex
ChemistryEurope · 2026-03 · 4 (3)
DOI: 10.1002/ceur.202500198 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemistryEurope, online erschienen am 17.03.2026. Verfasst von Maryam Akhgar und 1 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Association, DAAD.
Abstract (Originalsprache)
The design of artificial receptors that can selectively bind to specific oligonucleotide sequences presents a promising strategy for targeting various genetic diseases. Toward this goal, a cage‐like receptor was designed, combining triazine‐based anion‐binding macrocycles with a naphthalimide dye. The [2 + 2] macrocyclization product was investigated for its ability to bind nucleotides and longer sequences with different topologies. While the affinity of the receptor for nucleotides is moderate, the binding of parallel G‐quadruplexes is achieved with high affinity and a fluorescence enhancement. The receptor demonstrates excellent selectivity for parallel G‐quadruplex over nucleotide triphosphates, other topologies, and a double‐stranded DNA sequence. These findings indicate that triazine‐based receptors hold significant potential for efficient G‐quadruplex recognition.
Förderung
- German Research Association
- DAAD
Zitieren
APA
Akhgar, M., & Kataev, E. A. (2026). Triazine‐Naphthalimide Cage for the Recognition of Nucleotides and Parallel G‐Quadruplex. ChemistryEurope, 4(3). https://doi.org/10.1002/ceur.202500198
Vancouver
Akhgar M, Kataev EA. Triazine‐Naphthalimide Cage for the Recognition of Nucleotides and Parallel G‐Quadruplex. ChemistryEurope. 2026;4(3). doi:10.1002/ceur.202500198
BibTeX
@article{Akhgar2026,
author = {Akhgar, Maryam and Kataev, Evgeny A.},
title = {Triazine‐Naphthalimide Cage for the Recognition of Nucleotides and Parallel G‐Quadruplex},
journal = {ChemistryEurope},
year = {2026},
volume = {4},
number = {3},
doi = {10.1002/ceur.202500198}
}
EUVIMED